期刊
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
卷 33, 期 2, 页码 545-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2019.02.006
关键词
Fungal infections; Candidiasis; Aspergillosis; Mucormycosis; Hematologic malignancies; Hematopoietic stem cell transplant
资金
- Burden Family Valley Fever Fund
Despite advances in chemotherapy and supportive care, morbidity and mortality remain high for patients with hematologic malignancies (HMs). Those who require hematopoietic stem cell transplantation (HSCT) often require significant immunosuppression and are subject to a variety of complications. These patients carry multiple risk factors for infectious complications, including the development of invasive fungal infections, compared with the general population. Because antifungal prophylaxis has been widely adopted, there has been a shift away from invasive candidiasis toward invasive mold infections, including breakthrough infections. For patients with HM and HSCT, we outline the epidemiology, manifestations, diagnosis, and treatment of invasive fungal infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据